Share
- Release Date: 15/01/13 18:09
- Summary: RELINT: FPH: Disclosure of Director Relevant Interests
- Price Sensitive: No
- Download Document 1.7KB
FPH
15/01/2013 16:09
RELINT
REL: 1609 HRS Fisher & Paykel Healthcare Corporation Limited
RELINT: FPH: Disclosure of Director Relevant Interests
Name of director or officer of public issuer: Donal Paul O'DWYER
Name of public issuer: Fisher & Paykel Healthcare Corporation Limited
Name of related body corporate (if applicable): Not Applicable
Position held in public issuer: Director
B Securities in public issuer or any related body corporate in which director
or officer has relevant interest
Number, class, and type of securities: "(i) 20,000 Ordinary Shares;
(ii) 21,500 Ordinary Shares;
(iii) 9,850 Ordinary Shares"
C Nature of relevant interest and name of registered holder
Nature of relevant interest in securities: Beneficial
Name of registered holder of securities Dundrum Super Fund
D Details of acquisitions and disposals
If the relevant interest was acquired--
Date of acquisition: "(i) 9 January 2013; (ii) 10 January 2013;
(iii) 11 January 2013"
Consideration paid for acquisition: "(i) AUD$38,934.64; (ii) AUD
$42,297.67;
(iii) AUD $19,292.01"
If the relevant interest was disposed of--
Date of disposal: Not Applicable
Consideration paid for disposal: Not Applicable
Type of transaction
Describe the arrangement pursuant to which, or the circumstances in which,
the acquisition took place: "(i) Purchase of 20,000 Ordinary Shares;
(ii) Purchase of 21,500 Ordinary Shares;
(iii) Purchase of 9,850 Ordinary Shares as Trustee of Dundrum Super Fund"
E Total number of transactions this notice relates to: Three
F Date of last disclosure notice (whether in form 1 or form 2) by the
director or officer: 7 December 2012
End CA:00232046 For:FPH Type:RELINT Time:2013-01-15 16:09:47
